SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

XRP (XRP) is a cryptocurrency . XRP has a current supply of 99,985,583,260 with 63,516,606,953 in circulation. The last known price of XRP is 1.17847452 USD and is down -3.32 over the last 24 hours. It is currently trading on 1894 active market(s) with $2,362,443,159.56 traded over the last 24 hours. More information can be found at https://xrpl.org/.

Ripple

XRPs prolonged slide and perceived underperformance are driving bearish discussion, with traders citing broader crypto weakness and uncertainty over the Clarity Act after the midterms. Some blame Ripples token sales and question XRPs utility, while others view the decline as a buying opportunity and continue accumulating.

IonQ, Inc. develops and manufactures quantum computers. The firm specializes in quantum computing and quantum information processing. The company was founded by Christopher Monroe and Jung Sang Kim in 2015 and is headquartered in College Park, MD.

IonQ Inc

IonQs better-than-expected quarterly results and raised full-year revenue outlook sparked a sharp rally, with traders also pointing to growing backlog and quantum-computing demand. The upbeat reaction is tempered by debate over how much growth came from the SkyWater acquisition, as well as concerns about cash burn, dilution, and whether the gap-up can hold.

Snowflake, Inc. engages in the provision of cloud data warehousing software. The firm offers Data Cloud, an ecosystem where Snowflake customers, partners, data providers, and data consumers can break down data silos and derive value from data. Its platform supports a range of use cases including data warehousing, data lakes, data engineering, data science, data application development, and data sharing. The cloud-native architecture consists of layers across storage, compute, and cloud services. The storage layer ingests structured and semi-structured data to create a unified data record. The compute layer provides dedicated resources to enable users to access common data sets for many use cases without latency. The cloud services layer optimizes each use case's performance requirements with no administration. The company was founded by Marcin Zukowski, Thierry Cruanes, and Benoit Dageville on July 23, 2012 and is headquartered in Menlo Park, CA.

Snowflake Inc

Debate over Snowflakes consumption-based model is driving attention, with traders warning that tighter budgets could lead customers to cut queries, storage and AI workloads, pressuring usage-linked revenue. Others see the models flexibility as a source of recovery when spending improves, while dip buyers and bearish traders remain divided on the stocks direction.

Vertiv Holdings Co. engages in the design, manufacture, and service of critical digital infrastructure technology for data centers, communication networks, and commercial and industrial environments. The firm also offers power management products, switchgear and busbar products, thermal management products, integrated rack systems, modular solutions, and management systems for monitoring and controlling digital infrastructure. It operates through the following geographical segments: Americas, Asia Pacific, and Europe, Middle East, and Africa (EMEA). The Americas segment includes products and services sold for applications within the data center, communication networks and commercial and industrial markets in North America and Latin America. The Asia Pacific segment consists of products and services sold for applications within the data center, communication networks and commercial and industrial markets throughout Greater China, Asia, and India. The EMEA segment focuses on products and services sold for applications within the data center, communication networks, and commercial and industrial markets in Europe, Middle East, and Africa. The company was founded in 1946 and is headquartered in Westerville, OH.

Vertiv Holdings Co - Ordinary Shares - Class A

Vertiv Holdings Co

Vertivs stronger-than-expected quarterly results, raised outlook and more than doubled organic orders sparked a sharp rally, reinforcing optimism about demand for its data-center power and cooling systems. Some traders see confirmation that AI infrastructure spending remains robust, while skeptics point to permitting delays, financing risks and uncertainty over whether orders will translate into delivered revenue.

Salesforce, Inc. engages in the design and development of cloud-based enterprise software for customer relationship management. Its solutions include sales force automation, customer service and support, marketing automation, digital commerce, community management, collaboration, industry-specific solutions, and salesforce platform. The firm also provides guidance, support, training, and advisory services. The company was founded by Marc Russell Benioff and Parker Harris in 1999 and is headquartered in San Francisco, CA.

Salesforce Inc

Salesforces decline is drawing debate over whether it can monetize AI add-ons at renewals when customers may be cutting employee seat counts and software budgets. Traders question whether Agentforce can generate paid demand beyond bundled offers, while others focus on nearby technical support levels.

Strategy, Inc. engages in the development of fixed-income instruments that provide investors varying degrees of economic exposure to bitcoin. It executes bitcoin acquisition, capital management, and capital markets strategies. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Tysons Corner, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

Bitcoins sharp, volatile selloff is driving attention to Strategy as a leveraged BTC proxy, with traders debating whether the weakness could deepen the stocks losses. Bears also cite dilution, preferred-stock obligations and a possible MSCI removal as risks, while bulls argue the pullback is a buying opportunity and look for a rebound.

Arista Networks, Inc. engages in the development, marketing, and sale of cloud networking solutions. Its solutions include EOS, a set of network applications, and Gigabit Ethernet switching and routing platforms. Its product categories include core, cognitive adjacencies, and cognitive networks. The company was founded by Andreas Bechtolsheim, David Cheriton, and Kenneth Duda in November 2004 and is headquartered in Santa Clara, CA.

Arista Networks Inc

Aristas Q3 results beat expectations and its Q4 guidance topped forecasts, strengthening the AI-networking demand story and prompting a sharp rally. Traders are largely bullish on the growth outlook, though some warn that gains may fade and question whether hyperscaler data-center spending can sustain orders.

Teladoc Health, Inc. engages in the provision of telehealthcare services using a technology platform via mobile devices, the Internet, video and phone. It operates through the following segments: Teladoc Health Integrated Care, BetterHelp, and Others. The Teladoc Health Integrated Care segment offers virtual medical services. The BetterHelp segment includes virtual mental health and other wellness services. The company was founded in June 2002 by George Byron Brooks, Michael Gorton, and Gary Wald and is headquartered in New York, NY.

Teladoc Health Inc

Teladocs Q3 results, with improved profitability and cash generation, fueled a sharp rally and optimism about a turnaround; traders are also pointing to analyst upgrades and speculating about a short squeeze. Others remain cautious, citing declining revenue and ongoing BetterHelp challenges, while some see the latest pullback as profit-taking after the run.

Celsius Holdings, Inc. engages in the development, marketing, sale, and distribution of functional drinks and liquid supplements. It also offers post-workout functional energy drinks and protein bars. The company was founded in April 2004 and is headquartered in Boca Raton, FL.

Celsius Holdings Inc

Celsius drew attention after reporting a better-than-expected third quarter, with Alani Nu and international growth offsetting a decline in the flagship Celsius brand. Traders welcomed the beat but debated whether Alani can sustain portfolio growth, while margin compression and core-brand weakness tempered optimism.

Chewy, Inc. operates as an online retailer of pet food and other pet-related products and services. It supplies pet medications, food, treats and other pet-health products and services for dogs, cats, fish, birds, small pets, horses, and reptiles. It has a portfolio of pet healthcare offerings that includes Chewy Pharmacy, Connect with a Vet, and CarePlus, an exclusive suite of pet-first insurance and wellness plans. The company was founded by Ryan Cohen and Michael Day in September 2011 and is headquartered in Plantation, FL.

Chewy Inc - Ordinary Shares - Class A

Chewy Inc

Chewys post-earnings selloff is dominating discussion: traders point to soft organic growth, margin concerns and weaker quarterly free cash flow despite a raised full-year sales outlook. Bulls view the drop as an overreaction to a still-profitable business, while bears see persistent consumer weakness and limited growth as reasons for caution.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Here's Why IQVIA Holdings (IQV) is a Strong Momentum Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

WM Q3 Earnings Miss Estimates, Revenues Increase 6.3% Y/Y

WM's Q3 earnings miss estimates as higher fuel and risk management costs weigh on margins, while revenues beat expectations.

IQVIA Holdings Q3 Earnings Beat Estimates, Revenues Increase 8% Y/Y

IQV's Q3'26 earnings beat estimates as revenues rise 8% y/y, led by strong clinical demand, robust R&D bookings and improved execution, prompting a view hike.

IQVIA Holdings Q3 26 Earnings Conference Call At 9:00 AM ET

(RTTNews) - IQVIA Holdings Inc. (IQV) will host a conference call at 9:00 AM ET on October 27, 2026, to discuss Q3 26 earnings results...

IQVIA Holdings (IQV) Surpasses Q3 Earnings and Revenue Estimates

IQVIA (IQV) delivered earnings and revenue surprises of +3.09% and +1.44%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?

IQVIA Reports Third-Quarter 2026 Results

IQVIA Holdings Inc. (IQVIA) (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, today reported financial results for the quarter ended September 30, 2026. Year-Over-Year Comparisons As...

IQVIA Gears Up to Post Q3 Earnings: Here's What Investors Should Know

IQV is poised for y/y revenue and earnings growth in Q3, driven by stronger clinical research demand, solid bookings, AI adoption and operational efficiencies.

AxoGen (AXGN) Reports Next Week: Wall Street Expects Earnings Growth

AxoGen (AXGN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

IQVIA Holdings (IQV) Earnings Expected to Grow: Should You Buy?

IQVIA (IQV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

The $1 Trillion AI Healthcare Revolution: A New Era of Medical Innovation Is Taking Shape

AI-powered diagnostics, drug discovery and intelligent medical technology are opening the door to a potentially massive global market projected to reach $1 trillion by 2034   New York, NY – October 15, 2026 – Artificial intelligence is starting to change the way healthcare works, and the opportunity is getting harder to ignore. From spotting diseases […]
The post The $1 Trillion AI Healthcare Revolution: A New Era of Medical Innovation Is Taking Shape appeared first on Financial News Media.

• Reported GAAP EPS of $3.34 up 11.33% YoY
• Reported revenue of $4.43B up 8.00% YoY
• IQVIA raised full-year 2026 guidance: revenue of $17.35B to $17.5B, Adjusted EBITDA of $4.03B to $4.06B, and Adjusted Diluted Earnings per Share of $12.90 to $13.00.

IQVIA adjusted R&DS backlog by approximately $2.1B after an inactive-trial review, reported $13.82B net debt and 3.45x leverage, and disclosed short-notice termination and large-client contract risks.

IQVIA recorded year-over-year growth in Commercial Solutions and R&D Solutions, net new bookings rose 15% with over 400 AI agents deployed, and full-year 2026 guidance was raised.

IQVIA Holdings, Inc. engages in the provision of analytics, technology solutions, and clinical research services to the life sciences industry. It operates through the following segments: Technology and Analytics Solutions, Research and Development Solutions, and Contract Sales and Medical Solutions. The Technology and Analytics Solutions segment supplies mission-critical information, technology solutions, and real-world evidence services to the company's life sciences clients. The Research and Development Solutions segment provides outsourced clinical research and clinical trial-related services. The Contract Sales and Medical Solutions segment offers healthcare provider and patient engagement services to both biopharmaceutical customers and the broader healthcare market. The company was founded by Dennis B. Gillings and Gary Koch in 1950 and is headquartered in Durham, NC.

IQVIA Holdings Inc

Retail Raves About IQVIA Holdings After Firm Raises Revenue, Profit Guidance

Equity

Neutral Sentiment

IQVIA Holdings Inc, on Monday, reported an upbeat set of earnings that topped Wall Street estimates while also raising its revenue and earnings per share (EPS) guidance for 2024. Following the announcement, shares of the firm jumped nearly 7% and retail sentiment entered extremely bullish territory (76/100) from a neutral zone supported by extremely high message volumes.<figure class="image"><img style="aspect-ratio:795/228;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/Screenshot_2024_07_22_at_3_09_52_PM_e9a57ca2e1.png" alt="Retail sentiment trends in extremely bullish territory for IQVIA Holdings" width="795" height="228"><figcaption>Retail sentiment trends in extremely bullish territory for IQVIA Holdings</figcaption></figure>The firm, which provides advanced analytics, technology solutions, and clinical research services to the life sciences industry, reported a 2.30% year-over-year (YoY) rise in its second quarter revenue at $3.81 billion which stood higher than a Street estimate of $3.79 billion. Net income rose 22% YoY to $363 million during the quarter. The firm reported an adjusted diluted EPS of $2.64 as compared to a Street estimate of $2.57.IQVIA Holdings pointed out that as of June 30, 2024, Research &amp; Development Solutions (R&amp;DS) contracted backlog (including reimbursed expenses), stood at $30.60 billion–growing 7.70% year-over-year and 8.10% at constant currency. The company said it expects approximately $7.80 billion of this backlog to convert to revenue in the next twelve months.Ari Bousbib, chairman and CEO of IQVIA said the firm delivered second quarter results at the high-end of its guidance, driven mainly by better-than-expected Technology &amp; Analytics Solutions (TAS) performance. TAS revenue came in at $1.49 billion, registering an increase of 2.70% on a reported basis and 3.80% on a constant currency basis.The company has updated its full-year 2024 guidance for revenue to be between $15.43 billion and $15.53 billion, as compared to an earlier guidance of $15.33-15.58 billion. Adjusted earnings before interest, tax, depreciation, and amortization (EBITDA) is expected between $3.71 billion and $3.77 billion, compared with an earlier guidance of $3.70-3.80. Adjusted diluted EPS is estimated between $11.10 and $11.30 compared with an earlier guidance of $10.95-11.25.One Stocktwits user named ‘Wigglyick’ has expressed optimism on the technical pattern formed by the stock, which other users cited as evidence of its improving fundamental picture.<figure class="image"><a href="https://stocktwits.com/Wigglyick"><img style="aspect-ratio:784/612;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/Screenshot_2024_07_22_at_3_11_34_PM_d36f6ac6b2.png" alt="Stocktwits user Wigglyick's post on IQVIA Holdings" width="784" height="612"></a><figcaption>Stocktwits user Wigglyick's post on IQVIA Holdings</figcaption></figure> &nbsp;

IQVIA Holdings has updated its full-year 2024 guidance for revenue to be between $15.43 billion and $15.53 billion, as compared to an earlier guidance of $15.33-$15.58 billion. 

IQVIA Holdings has updated its full-year 2024 guidance for revenue to be between $15.43 billion and $15.53 billion, as compared to an earlier guidance of $15.33-$15.58 billion. Retail sentiment entered extremely bullish territory (77/100) from a neutral zone supported by extremely high message volumes.

First Trust Exchange-Traded Fund II - First Trust Nasdaq Lux Digital Health Solutions ETF

First Trust Exchange-Traded Fund III - First Trust Health Care AlphaDEX Fund

Invesco Bloomberg Pricing Power ETF

Invesco S&P 500 Equal Weight Health Care ETF

Vanguard Mid-Cap Growth ETF

Up more than 1% 

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Feed

News

Sentiment

Earnings

Fundamentals

Info

IQV News